Literature DB >> 23424264

Successful use of tocilizumab in a patient with psoriatic arthritis.

Michael Hughes, Hector Chinoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23424264     DOI： 10.1093/rheumatology/kes432

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

Review 1.  Psoriatic arthritis: latest treatments and their place in therapy.

Authors:  Eun Jin Kang; Arthur Kavanaugh
Journal:  Ther Adv Chronic Dis       Date:  2015-07       Impact factor: 5.091

Review 2.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

3.  Atherosclerosis in Psoriatic Arthritis: A Multiparametric Analysis Using Imaging Technique and Laboratory Markers of Inflammation and Vascular Function.

Authors:  Nidhi Garg; Pawan Krishan; Ashit Syngle
Journal:  Int J Angiol       Date:  2016-07-01

Review 4.  Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.

Authors:  Michitaro Hayakawa; Keisuke Izumi; Misako Higashida-Konishi; Mari Ushikubo; Masako Tsukamoto; Kumiko Akiya; Kazuhiro Araki; Hisaji Oshima
Journal:  Rheumatol Int       Date:  2018-10-24       Impact factor: 2.631

Review 5.  Advances in the management of psoriatic arthritis.

Authors:  Ignazio Olivieri; Salvatore D'Angelo; Carlo Palazzi; Angela Padula
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

Review 6.  Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies.

Authors:  Francesco Caso; Luisa Costa; Antonio Del Puente; Matteo Nicola Dario Di Minno; Gelsy Lupoli; Raffaele Scarpa; Rosario Peluso
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

7.  Efficacy of tocilizumab in a patient with refractory psoriatic arthritis.

Authors:  Luisa Costa; Francesco Caso; Luca Cantarini; Antonio Del Puente; Raffaele Scarpa; Mariangela Atteno
Journal:  Clin Rheumatol       Date:  2014-04-08       Impact factor: 2.980

8.  Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis.

Authors:  Jennifer Belasco; James S Louie; Nicholas Gulati; Nathan Wei; Kristine Nograles; Judilyn Fuentes-Duculan; Hiroshi Mitsui; Mayte Suárez-Fariñas; James G Krueger
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

9.  Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.

Authors:  Hanna Przepiera-Będzak; Katarzyna Fischer; Marek Brzosko
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

10.  IL-6 Signaling in Myelomonocytic Cells Is Not Crucial for the Development of IMQ-Induced Psoriasis.

Authors:  Sabrina Klebow; Matthias Hahn; Alexei Nikoalev; F Thomas Wunderlich; Nadine Hövelmeyer; Susanne H Karbach; Ari Waisman
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.